Compare AbCellera Biologics Inc (ABCL) vs Monolithic Power Systems Inc (MPWR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Monolithic Power Systems Inc — how do they compare? AbCellera Biologics Inc trades at $9.1 (market cap $2.99B), while Monolithic Power Systems Inc trades at $1,425 (market cap $68.90B). The key difference: Monolithic Power Systems Inc is far larger — about 23× AbCellera Biologics Inc's market cap, and Monolithic Power Systems Inc pays a 0.57% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | MPWR | |
|---|---|---|
Market Cap | $2.99B | $68.90B |
Sector | Health | Utilities |
52-Week High | $9.76 | $1.69K |
52-Week Low | $2.78 | $820.74 |
Enterprise Value | $2.58B | $67.51B |
Dividend Yield | — | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Monolithic Power Systems Inc
Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →
